2019³â Á¦10Â÷ Çѱ¹Á¶Á÷°øÇÐÀç»ýÀÇÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2019-11-22±³À°ÀÏÀÚ : 2019-11-22
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø ´ë°´ç, 1002È£
±³À°ÁÖÁ¦ :
2019³â Á¦10Â÷ Çѱ¹Á¶Á÷°øÇÐÀç»ýÀÇÇÐȸ ±³À°½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ
´ã´çÀÚ : ±è°æ¹Î
¿¬¶ôó : 070-7558-2608
À̸ÞÀÏ :
kterms@gmail.com ±³À°Á¾·ù : »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ¼ºÇü¿Ü°ú, À̺ñÀÎÈÄ°ú, ½Å°æ°úºÐÀÚ»ý¹°ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 11 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 220,000¿ø
ºñ°í -Á¤È¸¿ø[»çÀüµî·Ï] ÀÏ¹Ý : 160,000 / Çлý : 110,000[ÇöÀåµî·Ï] ÀÏ¹Ý : 200,000 / Çлý : 130,000-ºñȸ¿ø[»çÀüµî·Ï] ÀÏ¹Ý : 180,000 / Çлý : 120,000[ÇöÀåµî·Ï] ÀÏ¹Ý : 220,000 / Çлý : 140,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-22 ´ë°´ç 09:10~09:50 ÷´ÜÀç»ý¹ÙÀÌ¿À¹ý ÀÌÇØ ¹× ÇÐȸÀÇ ¿ªÇÒ ¹Ú¼Ò¶ó(ÀÎÇÏ´ë)
ÈÞ½Ä 11-22 09:50~10:00 coffee break ()
±³À°½Ã°£ 11-22 ´ë°´ç 10:00~10:30 Stem Cells with Microfluidics ±èÁ¾ÈÆ(°í·Á´ë)
±³À°½Ã°£ 11-22 ´ë°´ç 10:30~11:00 Achieving Complete iPS cell Reprogramming À̸¸·Ä(¼øõÇâ´ë)
±³À°½Ã°£ 11-22 ´ë°´ç 11:00~11:30 ¼¼Æ÷¿Ü ±âÁú(ECM)ÀÇ ÀÌÇØ¿Í ÀÀ¿ë ¹Ú±Í´ö(KIST)
±³À°½Ã°£ 11-22 1002È£ 10:00~10:20 Unmet needs in Digestive Systems ±èÀº¼±(°í·Á´ë ¾È¾Ïº´¿ø)
±³À°½Ã°£ 11-22 1002È£ 10:20~10:40 Unmet needs in Cartilage Regeneration ±è¼ºÈ¯(¿¬¼¼´ë ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 11-22 1002È£ 10:40~11:00 Unmet Needs in Upper Aerodigestive Tract ½ÅÀ¯¼·(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 11-22 1002È£ 11:00~11:20 Unmet needs in Plastic Surgery ÇãÂù¿µ(ºÐ´ç¼¿ï´ëº´¿ø)
ÈÞ½Ä 11-22 11:30~11:40 coffee break ()
±³À°½Ã°£ 11-22 ´ë°´ç 11:40~12:10 ¾Ï ¿À°¡³ëÀ̵带 ÀÌ¿ëÇÑ ½Å¾à ½ºÅ©¸®´× Àü·« Àå¼¼Áø(¿ï»ê´ë)
±³À°½Ã°£ 11-22 ´ë°´ç 12:10~12:40 Á¶Á÷º° ¿À°¡³ëÀÌµå ¹è¾ç¹æ¹ý Á¤´ÙÁ¤(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 11-22 1002È£ 11:40~12:10 ³í¹®ÀÛ¼ºÀ» À§ÇÑ ImageJ È«¼Ò¿µ(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 11-22 1002È£ 12:10~12:40 Data analysis for journal papers ÃÖ¼º¿í(°¿ø´ë)
½Ä»ç 11-22 12:40~14:00 Lunch ()
±³À°½Ã°£ 11-22 ´ë°´ç 14:00~14:40 Facilitating Tissue Regeneration and Cell therapies using 3D Bioprinting ordon Wallace((Wollongong Univ. Australia)
ÈÞ½Ä 11-22 14:40~14:50 coffee break ()
±³À°½Ã°£ 11-22 ´ë°´ç 14:50~15:20 À¯ÀüÀÚ ÆíÁý ±â¼ú ¼Ò°³ ¼º¿µÈÆ(¿ï»ê´ë)
±³À°½Ã°£ 11-22 ´ë°´ç 15:20~15:50 CRSIPR/Cas9-mediated gene engineering and its applications in therapuetics Àå¹ÌÈñ(KIST)
±³À°½Ã°£ 11-22 ´ë°´ç 15:50~16:20 Application of Gene Editing for Cancer Immunotherapy ÀÌ¸í¼·(¿ï»ê´ë)
±³À°½Ã°£ 11-22 1002È£ 14:50~15:20 Early start-up ³ªµµ ȸ»ç¸¦ ¸¸µé ¼ö ÀÖÀ»±î? ÁÖÁöÇö(¼¿ï¼º¸ðº´¿ø / (ÁÖ)Cistem)
±³À°½Ã°£ 11-22 1002È£ 15:20~15:50 ´ëÇÐ ½ÇÇè½Ç¿¡¼ÀÇ Ã¢¾÷ Á¤¼®(°í·Á´ë / (ÁÖ)ÀÎÅعÙÀÌ¿À)
±³À°½Ã°£ 11-22 1002È£ 15:50~16:20 ½ºÅ¸Æ®¾÷, ÅõÀÚ ±×¸®°í ÆÁ½º ±èÆÇ°Ç(¹Ì·¡°úÇбâ¼úÁöÁÖ)
ÈÞ½Ä 11-22 16:20~16:30 coffee break ()
±³À°½Ã°£ 11-22 ´ë°´ç 16:30~16:55 Development of Engineered Antibodies for Effective Diagnostics and Immunotherapy Á¤ÈñÁø(È«ÀÍ´ë)
±³À°½Ã°£ 11-22 ´ë°´ç 16:55~17:20 CD8 T cell diversity in tumor Á¤¿¬¼®(¼¿ï´ë)
±³À°½Ã°£ 11-22 ´ë°´ç 17:20~17:45 Employing the dual nature of T cells for Immunotherapy ¹ÚÀ±(KIST)
±³À°½Ã°£ 11-22 1002È£ 16:30~17:05 3D ¹ÙÀÌ¿ÀÇÁ¸°Æà ±â¼ú ±â¹ÝÀÇ Ã¢¾÷°ú IPO±îÁö À±¿ø¼ö(Çѱ¹»ê¾÷±â¼ú´ë / (ÁÖ)Ƽ¾Ø¾Ë¹ÙÀÌ¿ÀÆÕ)
±³À°½Ã°£ 11-22 1002È£ 17:05~17:40 ¹ÙÀÌ¿Àº¥Ã³ÀÇ ¼ºÀå°úÁ¤¿¡¼ VC¿ÍÀÇ °ü°è: ¾î¶² ÆÄÆ®³Ê°¡ µÉ °ÍÀΰ¡? Ȳ¸¸¼ø(Çѱ¹ÅõÀÚÆÄÆ®³Ê½º)
±âŸ 11-22 17:45~18:00 °æÇ°Ãß÷ ()